Using complementarity determining region 3 (CDR3) spectratyping, Wada et al. demonstrated reduced diversity of the T cell receptor β (TRB) repertoire in WAS patients >15 years of age (20). This evidence concerns the gene THRB and Wiskott-Aldrich syndrome.